Non-clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Non-clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma [Phase 2]
This update notes a Phase 2 clinical trial investigating the combination of tivozanib and nivolumab in advanced non-clear cell renal cell ca…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors [Phase 1]
KO-2806 is being studied in Phase 1 trials as a monotherapy and in combination regimens for advanced solid tumors, including HRAS-altered ca…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma [Phase 1, Phase 2]
A clinical trial update on AK104 plus axitinib in advanced/metastatic special pathological subtypes of renal cell carcinoma (Phase 1/Phase 2…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of Sullumab and Fruquintinib as postoperative adjuvant therapy for high-risk non-clear cell renal c…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors [Phase 1]
A Phase 1 study evaluating Zanzalintinib in combination with immuno-oncology agents in patients with various solid tumors; recruitment is on…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61) [Phase 2]
A Phase 2 trial evaluated pembrolizumab plus lenvatinib as first-line therapy for advanced/non-clear cell renal cell carcinoma. Results have…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC [Phase 2]
A randomized Phase II trial comparing nivolumab plus ipilimumab to standard of care in untreated and advanced non-clear cell renal cell carc…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 study of nivolumab in combination with cabozantinib in patients with non-clear cell renal cell carcinoma; the trial is currently act…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma [Phase 3]
Phase 3 study evaluating XL092 in combination with nivolumab versus sunitinib in advanced or metastatic non-clear cell renal cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial) [Phase 2]
A Phase 2 trial of lenvatinib plus pembrolizumab in locally advanced or metastatic non-clear cell renal cell carcinoma was terminated. Resul…
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Fruquintinib and SeRplulimab: Opening New Frontiers in Treating Non-clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating Fruquintinib plus SeRplulimab for non-clear renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Anlotinib Plus Sintilimab as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma [Phase 2]
A phase 2 clinical trial evaluating anlotinib in combination with sintilimab as first-line therapy for advanced non Clear Cell Renal Cell Ca…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial comparing everolimus to sunitinib in non-clear cell renal cell carcinoma was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma [Phase 2]
A Phase 2 study evaluating the combination of atezolizumab and bevacizumab in patients with advanced non-clear cell renal cell carcinoma has…
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease [Phase 2]
Phase 2 trial evaluating the combination of lenvatinib and everolimus in unresectable advanced or metastatic non-clear cell renal cell carci…
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab plus axitinib as neoadjuvant therapy for advanced/metastatic non-clear cell renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: pazopanib_NCRCC,Ph2 STUDY [Phase 2]
A Phase 2 clinical trial of pazopanib for locally advanced or metastatic non-clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma [Phase 2]
Phase II trial comparing Afinitor to Sutent in metastatic non-clear cell renal cell carcinoma has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer [Phase 2]
Phase 2 trial of sunitinib malate in patients with non-clear cell renal cell carcinoma has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe [Phase 2]
Phase 2 trial RAPTOR evaluated RAD001 (everolimus) as monotherapy for advanced papillary renal cell carcinoma; the study is completed with r…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib [Phase 2]
Phase 2 study comparing temsirolimus and sunitinib in non-clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients [Phase 2]
This Phase 2 clinical trial evaluating capecitabine for metastatic non-clear cell renal cell carcinoma has completed.